Cargando…

The cytosolic 5′-nucleotidase cN-II lowers the adaptability to glucose deprivation in human breast cancer cells

The cytosolic 5’-nucleotidase cN-II is a highly conserved enzyme implicated in nucleotide metabolism. Based on recent observations suggesting additional roles not directly associated to its enzymatic activity, we studied human cancer cell models with basal or decreased cN-II expression. We developed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bricard, Gabriel, Cadassou, Octavia, Cassagnes, Laure-Estelle, Cros-Perrial, Emeline, Payen-Gay, Léa, Puy, Jean-Yves, Lefebvre-Tournier, Isabelle, Tozzi, Maria Grazia, Dumontet, Charles, Jordheim, Lars Petter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620180/ https://www.ncbi.nlm.nih.gov/pubmed/28978040 http://dx.doi.org/10.18632/oncotarget.18653

Ejemplares similares

Transcriptional and Metabolic Investigation in 5′-Nucleotidase Deficient Cancer Cell Lines
por: Cadassou, Octavia, et al.
Publicado: (2021)

Cytosolic 5’-Nucleotidase II Interacts with the Leucin Rich Repeat of NLR Family Member Ipaf
por: Cividini, Federico, et al.
Publicado: (2015)

Structural Insights into the Inhibition of Cytosolic 5′-Nucleotidase II (cN-II) by Ribonucleoside 5′-Monophosphate Analogues
por: Gallier, Franck, et al.
Publicado: (2011)

Recent advances in structure and function of cytosolic IMP-GMP specific 5′nucleotidase II (cN-II)
por: Ipata, Piero Luigi, et al.
Publicado: (2006)

Cytosolic 5′-Nucleotidase II Is a Sensor of Energy Charge and Oxidative Stress: A Possible Function as Metabolic Regulator
por: Pesi, Rossana, et al.
Publicado: (2021)

Cytosolic 5′-Nucleotidase II Silencing in Lung Tumor Cells Regulates Metabolism through Activation of the p53/AMPK Signaling Pathway
por: Pesi, Rossana, et al.
Publicado: (2021)

A Proposed Methodology to Deal with the Impact of In Vitro Cellular Matrix on the Analytical Performances of a Targeted Metabolomic LC-HRMS Method
por: Guitton, Jérôme, et al.
Publicado: (2023)

Expression of Bovine Cytosolic 5′-Nucleotidase (cN-II) in Yeast: Nucleotide Pools Disturbance and Its Consequences on Growth and Homologous Recombination
por: Allegrini, Simone, et al.
Publicado: (2013)

Cytosolic 5′-Nucleotidase II Silencing in a Human Lung Carcinoma Cell Line Opposes Cancer Phenotype with a Concomitant Increase in p53 Phosphorylation
por: Pesi, Rossana, et al.
Publicado: (2018)

Evidence for a Cross-Talk Between Cytosolic 5′-Nucleotidases and AMP-Activated Protein Kinase
por: Camici, Marcella, et al.
Publicado: (2020)

5'-nucleotidase cN-II emerges as a new predictive biomarker of response to gemcitabine/platinum combination chemotherapy in non-small cell lung cancer
por: Toffalorio, Francesca, et al.
Publicado: (2018)

Spatial and Temporal Control of Cavitation Allows High In Vitro Transfection Efficiency in the Absence of Transfection Reagents or Contrast Agents
por: Chettab, Kamel, et al.
Publicado: (2015)

Anti–Cytosolic 5′‐Nucleotidase 1A Autoantibodies Are Absent in Juvenile Dermatomyositis
por: Rietveld, Anke, et al.
Publicado: (2021)

Substrate-Based Design of Cytosolic Nucleotidase IIIB Inhibitors and Structural Insights into Inhibition Mechanism
por: Kubacka, Dorota, et al.
Publicado: (2022)

Resistance to gemcitabine in a human follicular lymphoma cell line is due to partial deletion of the deoxycytidine kinase gene
por: Galmarini, Carlos María, et al.
Publicado: (2004)

Identification of allosteric inhibitors of the ecto-5'-nucleotidase (CD73) targeting the dimer interface
por: Rahimova, Rahila, et al.
Publicado: (2018)

Autoantibodies to Cytosolic 5′-Nucleotidase 1A in Primary Sjögren’s Syndrome and Systemic Lupus Erythematosus
por: Rietveld, Anke, et al.
Publicado: (2018)

Cytosolic 5′-nucleotidase 1A autoantibody profile and clinical characteristics in inclusion body myositis
por: Lilleker, J B, et al.
Publicado: (2017)

Clinical utility of anti‐cytosolic 5’‐nucleotidase 1A antibody in idiopathic inflammatory myopathies
por: Ikenaga, Chiseko, et al.
Publicado: (2021)

Crystal Structures of the Novel Cytosolic 5′-Nucleotidase IIIB Explain Its Preference for m(7)GMP
por: Monecke, Thomas, et al.
Publicado: (2014)

Monodisperse polysarcosine-based highly-loaded antibody-drug conjugates
por: Viricel, Warren, et al.
Publicado: (2019)

Investigating cytosolic 5′-nucleotidase II family genes as candidates for neuropsychiatric disorders in Drosophila (114/150 chr)
por: Singgih, Euginia L., et al.
Publicado: (2021)

A systemically administered detoxified TLR4 agonist displays potent antitumor activity and an acceptable tolerance profile in preclinical models
por: Chettab, Kamel, et al.
Publicado: (2023)

Cytosolic 5′-nucleotidase 1A is overexpressed in pancreatic cancer and mediates gemcitabine resistance by reducing intracellular gemcitabine metabolites
por: Patzak, Melanie S., et al.
Publicado: (2019)

Synthesis and Evaluation of a Molecularly Imprinted Polymer for Selective Solid-Phase Extraction of Irinotecan from Human Serum Samples
por: Roy, Béatrice, et al.
Publicado: (2012)

Discovery of Mitochondrial Complex I Inhibitors as Anticancer and Radiosensitizer Drugs Based on Compensatory Stimulation of Lactate Release
por: Lan, Junjie, et al.
Publicado: (2022)

About Pyrimidine 5’-Nucleotidase Deficiency
por: Özsoylu, Şinasi
Publicado: (2013)

Characterization of T‐DM1‐resistant breast cancer cells
por: Sauveur, Juliette, et al.
Publicado: (2020)

Anti-Cytosolic 5′-Nucleotidase 1A in the Diagnosis of Patients with Suspected Idiopathic Inflammatory Myopathies: An Italian Real-Life, Single-Centre Retrospective Study
por: Porcelli, Brunetta, et al.
Publicado: (2023)

Ecto-5’-nucleotidase: Structure function relationships
por: Sträter, Norbert
Publicado: (2006)

Intracellular Distribution of 5' Nucleotidase in Rat Liver
por: de Lamirande, Gaston, et al.
Publicado: (1958)

CYTOCHEMICAL LOCALIZATION OF 5'-NUCLEOTIDASE IN SUBCELLULAR FRACTIONS ISOLATED FROM RAT LIVER : I. The Origin of 5'-Nucleotidase Activity in Microsomes
por: Widnell, Christopher C.
Publicado: (1972)

Substrate Specificity of Chimeric Enzymes Formed by Interchange of the Catalytic and Specificity Domains of the 5′-Nucleotidase UshA and the 3′-Nucleotidase CpdB
por: Cabezas, Alicia, et al.
Publicado: (2021)

Physiological roles for ecto-5’-nucleotidase (CD73)
por: Colgan, Sean P., et al.
Publicado: (2006)

PARP Inhibitors and Proteins Interacting with SLX4
por: Jordheim, Lars Petter
Publicado: (2023)

Neutrophils protect lymphoma cells against cytotoxic and targeted therapies through CD11b/ICAM-1 binding
por: Hirz, Taghreed, et al.
Publicado: (2017)

Expression Profiling of Ribosome Biogenesis Factors Reveals Nucleolin as a Novel Potential Marker to Predict Outcome in AML Patients
por: Marcel, Virginie, et al.
Publicado: (2017)

Effect of Tenofovir on Nucleotidases and Cytokines in HIV-1 Target Cells
por: Biswas, Nabanita, et al.
Publicado: (2013)

Morphine treatment alters nucleotidase activities in rat blood serum
por: Rozisky, Joanna Ripoll, et al.
Publicado: (2012)

Bacillus subtilis 5′-nucleotidases with various functions and substrate specificities
por: Terakawa, Ayako, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_9omfeum5j0rncto14m0uk8e5pg